ASM19-08-05_AS_001436_600x300
Sponsored by:
Location:
Marriott Marquis Chicago (Grand Horizon Ballroom, Level 4) 

Monday,  July 29, 2024 – Chicago, IL (USA)

 

Held in conjunction with the ADLM 2024 (formerly AACC Annual Meeting & Clinical Lab Expo) 
Register Now

Please read carefully for the registration option that applies best for you:

  • Already registered for the expo, the scientific conference or as an exhibitor? Please REGISTER here.
  • Haven’t registered yet for anything? Please REGISTER here. 

Please Note: If you have received your confirmation email for IMB registration, there is no need for further action.

 

Learn about Global IVD Market Trends

ADLM welcomes you to join us at the 2024 International Market Briefing & Financial Analyst Briefing held in conjunction with the ADLM 2024 (formerly AACC Annual Meeting & Clinical Lab Expo).

We are inviting international company executives and financial analysts to hear about IVD market sectors and trends, learn the latest developments in world and emerging markets, and network with colleagues. Registration is required by Wednesday, July 24.

Who Should Attend

This program, now combined with the Financial Analyst Briefing, is intended to benefit international marketing executives, financial analysts, trade specialists, distributors, and others responsible for international marketing and sales.

Registration

Secure your seat in advance. The program is free to attend, but registration is required by Wednesday, July 24.

*Please note: Our registration process has changed. When registering you may be prompted to create a profile.

Registration for the International Market Briefing also grants access to ADLM 2024 Clinical Lab Expo, on Tuesday, July 30th - Thursday, August 1, 2024. Registration for ADLM 2024 (formerly AACC Annual Meeting & Clinical Lab Expo) conference is not included. If you would like to attend the ADLM 2024 conference, in addition to the International Market Briefing, please be sure to register separately for each event.

If you have questions, please contact ADLM Customer Service at custserv@myadlm.org.

Register Now

Program Agenda

Sessions will begin at 8:15 a.m. Central Time. Exclusive content will be available after the sessions.

Registration Deadline: July 24

7:15 – 11:00 A.M. | Registration Open

7:55 – 8:15 A.M. | Networking Time (Coffee/Continental Breakfast)

8:15 – 8:20 A.M. | ADLM CEO Welcome

Golden_Mark_2017 01-min

Mark J. Golden, FASAE, CAE

ADLM CEO

8:20 – 8:30 A.M. | ADLM President Welcome Address

Peck-Palmer_Octavia_2023_edit-1

Octavia Peck Palmer, PhD

ADLM President

8:30 – 8:40 A.M. | Speaker Introductions & Program Moderator

KristinPothier1VO-1-1-1

Kristin Pothier

Life Sciences Sector Leader, Global Deal Advisory and Strategy Leader, Healthcare and Life Sciences, KPMG Boston, MA, USA

 

8:40 – 9:25 A.M. | Global IVD Market Update

Overview of the worldwide IVD market trends.

001

Mark Girardi

Principal, Head of IVD, Diagnostic Consulting, IQVIA

2cbc9f1a-082b-432e-a754-b04ca0759cb0

Kaitlin Vautour

Consultant, IQVIA

9:25 – 10:15 A.M. | Data Analytics at Work in the Clinical Lab

Dr. Gabriel M. Garcia

Dr. Gabriel M. Garcia, PharmD

Clinical Innovations Specialist, TriCore Reference Laboratories

9:25 – 9:50 AM: The Analytical Edge - Enhancing Value-Based Care with Clinical Lab Insights:  By leveraging laboratory results, laboratories can proactively assist their clients in understanding their patient populations more comprehensively and improve health and reimbursement in a value-based care (VBC) landscape. Completing risk adjustments and meeting Healthcare Effectiveness Data and Information Set (HEDIS) measures is a crucial concept in the healthcare industry. Dr. Garcia will present a case study from a New Mexico prenatal cohort that demonstrates the effectiveness of laboratory derived insights in a VBC model that improved patient outcomes by closing care gaps and addressing risk factors.

Marci Dop

Marci Dop

Vice President of Enterprise Lab Operations, ELLKAY

9:50 – 10:15 AM:   During the presentation, interoperability expert Marci Dop will highlight the critical role that data integrity and quality play in realizing an effective artificial intelligence (AI) strategy. Given that around 86% of healthcare providers, life science companies, and tech vendors now utilize AI in various capacities, having a robust data management strategy is pivotal. Attendees will gain insights into the significance of a comprehensive data access strategy that emphasizes completeness, quality, and integrity. The session will offer a practical approach on producing and implementing a data strategy to fuel an organization’s AI vision. Key takeaways will include a healthcare use case as well as actionable direction for ensuring real world data access while maintaining data quality, along with the impact of data integrity on AI outcomes, and strategic approaches to integrate data management with AI initiatives.

10:15 – 10:30 A.M. | Connections in Precision Medicine Documentary

Highlights from KPMG’s documentary showcasing the ecosystem making precision medicine possible for patient care.

10:30 – 10:45 A.M. | Break/Networking Time

10:45 – 11:15 A.M. | Deal Making in Global Life Sciences

Jessica_Lin_hubspot-landing

Jessica Lin

Partner, KPMG

Hear about the current M&A and deal making trends affecting the clinical laboratory market. With deals more complex, involving more stakeholders, continued integration of data and digital, this session highlights recent changes and trends in deals and partnerships.

11:15 – 11:45 A.M. | Perspectives on the International Fundraising Environment for Tools and Diagnostics Companies

The life sciences investment landscape is constantly evolving. Challenges such as heightened antitrust scrutiny, capital costs, regulations, and geopolitical tensions face companies and the industry at large. However, amidst these challenges, there are bright spots. The advent of new technologies, coupled with the demand for personalized medicine, and the growth of emerging markets, paint a promising picture for the diagnostics sector.

Join us for an insightful panel on the complexities of sourcing deals and identifying the right investors within a global context. Panelists represent companies from Germany, Canada, and the United States, and will provide their unique perspectives on the challenges they face and the opportunities that lie ahead.

Christoph Brandenberger

Christoph Brandenberger

Moderator

Tony Ebert

Tony Ebert

Panelist: Laboratory Services and Partnership Development Director, Mayo Clinic

Martin Verhoef

Martin Verhoef

Panelist: Chief Business Officer, OMAPix

youssef

Youssef Helwa

Panelist: CEO, FluidAI Medical

11:45 A.M. – Noon | Wrap-up/closing remarks

KristinPothier1VO-1-1-1

Kristin Pothier

Life Sciences Sector Leader, Global Deal Advisory and Strategy Leader, Healthcare and Life Sciences, KPMG Boston, MA, USA

12:00 Noon | Session Closed